WASHINGTON, Jan. 8, 2015 /PRNewswire/ -- Intellectual property law firm Sterne, Kessler, Goldstein & Fox P.L.L.C. is proud to announce that Richard D. Coller III, Nirav N. Desai, Jeremiah B. Frueauf, Jonathan M. Strang, Jonathan Tuminaro, Ph.D. and Dennies Varughese, Pharm.D. have been elected to the directorship, effective January 1, 2015. These six new directors make up the largest class in the firm's history.
-- Richard D. Coller III is a director in the Mechanical Group. He focuses
his practice on conducting complex contested proceedings at the USPTO,
providing opinions of counsel, and obtaining patent protection for
cutting edge technologies in the medical device and consumer products
arenas. Coller is particularly skilled at identifying portfolio
strengths and weaknesses and providing strategic advice on portfolio
development and management. Prior to joining Sterne Kessler, Coller
worked as a biomedical engineering university research assistant
focusing on the design and testing of surgical implants and the
development of biosensors for medical and counter-terrorism
applications. Coller received his J.D., cum laude from the University
of Minnesota and his B.S. cum laude in Biomedical Engineering from
Tulane University.
-- Nirav N. Desai is a director in the Litigation Group. He represents
clients in a wide range of technology in district court, before the
Patent Trial and Appeal Board, and at the Federal Circuit. Throughout
his legal career, Desai has handled cases involving computer hardware
and software, semiconductors, RFID, networking devices, power systems,
medical devices, and pharmaceuticals, among others. Desai also has
experience counseling clients in intellectual property strategy,
including patent portfolio development and analysis, licensing, and
freedom to operate. Before his legal career, Desai worked in the
private sector as a software engineer and systems analyst with a focus
on developing biometric information systems for various government
agencies including the Department of Justice and the FBI. Desai
obtained his J.D. from The College of William and Mary, where he was a
member of the William and Mary Law Review. He earned his B.S. in
Computer Science from the University of Virginia School of Engineering
and Applied Sciences.
-- Jeremiah B. Frueauf is a director in the Biotechnology/Chemical Practice
Group and counsels domestic and international clients on the worldwide
procurement, protection, and enforcement of patents. He is experienced
in counseling clients on evaluating intellectual property, including
freedom-to-operate, due diligence, validity, infringement, and
patentability analyses, and identifying and implementing strategies for
licensing, challenging, designing-around, and securing a competitive
advantage over competitor technologies. Frueauf's experience includes
representing clients in various inter partes matters, including district
court litigation, Section 337 investigations before the U.S.
International Trade Commission, and patent office litigation. Frueauf
received his J.D from Georgetown University, his M.S. in Biochemistry
from Michigan State University and his B.S. in Chemistry/Biochemistry
from Ohio University, where he graduated summa cum laude.
-- Jonathan M. Strang is a director in the firm's Litigation Group. He
focuses his practice on representing technology clients before the
courts and the United States Patent & Trademark Office. To his legal
practice Strang brings broad practical experience including clerking in
the United States Court of Appeals for the Federal Circuit and the
United States Court of Federal Claims, serving as an officer in the U.S.
Navy Submarine Force as a nuclear and electrical engineer and in the
private sector leading various systems and software development efforts.
Strang earned his J.D. magna cum laude from George Mason University
where he was the Executive Editor of the Federal Circuit Bar Journal.
He earned his B.S. in Computer Engineering, summa cum laude from Auburn
University.
-- Jonathan Tuminaro, Ph.D., is a director in the Litigation Group. He
focuses his practice on complex patent litigation matters in the U.S.
district courts, the ITC, and the Patent Office. He has handled cases
spanning a wide range of technologies, including 4G wireless
communications, hand-held devices, billing systems, controlled-release
pharmaceuticals, in vivo imaging, and virtual machines. Tuminaro also
has experience preparing and prosecuting patent applications in a
variety of technical fields. To his legal practice, Tuminaro brings
extensive academic study in electromagnetism, classical and quantum
mechanics, quantum field theory, gravity theory, cognitive theory, and
artificial intelligence. Tuminaro earned his J.D. from George Mason
University, his Ph.D. in Physics from the University of Maryland, his
M.S. in Physics from University of Maryland, and his B.S. in Physics and
Mathematics, from Canisius College, where he graduated magna cum laude.
-- Dennies Varughese, Pharm.D., is a director in the Litigation Group and
specializes in biotech and pharmaceutical patent litigation in district
courts, and well as contested proceedings before the Patent Trial and
Appeal Board at the Patent Office. Throughout his legal career, Dr.
Varughese has handled cases involving a broad range of technologies in
the pharmaceutical and biotechnological arts, including
controlled-release polymers, hypoglycemic treatments, antilipidemic
treatments, antimalarials, microfluidics, and in vivo imaging, among
others. Dr. Varughese also has extensive experience counseling clients
on FDA regulatory matters, early commercialization strategies, drug
products liability, and antitrust issues bearing on pharmaceutical
patent settlements. He earned his J.D. cum laude from Temple
University, where he served as associate editor on the Law Review and
was awarded the Barrister Award for excellence in trial advocacy, the
Podwil Memorial Prize for excellence in intellectual property and the
Matkoff Scholarship award. Dr. Varughese earned his Doctor of Pharmacy
degree from the University of the Sciences, Philadelphia and is a
licensed pharmacist by the Commonwealth of Pennsylvania.
Sterne, Kessler, Goldstein & Fox P.L.L.C. is one of the largest U.S. law firms focused solely on the protection, transfer and enforcement of Intellectual Property Rights. Founded in 1978 and based in Washington, DC, the firm has more than 170 patent attorneys, agents and technical specialists representing a broad range of clients, including emerging and established companies, venture capital firms, universities and select individuals.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sterne-kessler-goldstein--fox-announces-election-of-largest-director-class-in-firm-history-300017941.html
SOURCE Sterne, Kessler, Goldstein & Fox P.L.L.C.
